However, genes that are classical AR targets in prostate cancer were not significantly altered by androgen stimulation in melanoma cells, suggesting that the dynamic transcriptional repertoire of AR in melanoma is distinct from that in prostate cancer cells (Supplementary Fig. 2f). This evidence concerns the gene AR and prostate cancer.